Bengaluru — Moderna said on Monday its Covid-19 vaccine produced virus-neutralising antibodies in laboratory tests against new coronavirus variants found in the UK and SA.

A two-dose regimen of the Moderna Covid-19 vaccine is expected to be protective against emerging strains detected to date, the company said...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.